7.77

2.88% -0.23

After Hours: 7.75 -0.02 -0.26%

Olema Pharmaceuticals Inc (OLMA)

Overview News Price History Option Chain Financials Discussions Forecast

Olema Pharmaceuticals Inc stock is traded at $7.77, with a volume of 1.34M. It is down -2.88% in the last 24 hours and up +46.33% over the past month. Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Previous Close:

$8.00

Open:

$7.98

24h Volume:

1.34M

Relative Volume:

1.75

Market Cap:

$533.29M

Revenue:

Net Income/Loss:

$-96.66M

P/E Ratio:

-3.614

EPS:

-2.15

Net Cash Flow:

$-83.73M

1W Performance:

-6.50%

1M Performance:

+46.33%

6M Performance:

+72.28%

1Y Performance:

-34.43%

1-Day Range:

$7.75

$8.197

1-Week Range:

$7.215

$8.52

52-Week Range:

$2.86

$13.93

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name

Olema Pharmaceuticals Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

(415) 651-3316

Address

780 BRANNAN STREET, SAN FRANCISCO

Employee

117

Twitter

Next Earnings Date

2025-03-18

Latest SEC Filings

OLMA's Discussions on Twitter

Compare OLMA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OLMA Olema Pharmaceuticals Inc	7.77	536.03M	0	-96.66M	-83.73M	-2.15
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-25	Reiterated	Citigroup	Buy
Apr-02-24	Initiated	Goldman	Buy
Jan-30-24	Initiated	Citigroup	Buy
Jul-21-23	Initiated	Oppenheimer	Outperform
May-05-23	Initiated	CapitalOne	Overweight
Feb-22-23	Initiated	Credit Suisse	Outperform
Jul-06-22	Resumed	Canaccord Genuity	Buy
Jun-09-22	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-28-22	Initiated	H.C. Wainwright	Neutral
Dec-07-21	Resumed	Cowen	Outperform
Dec-14-20	Initiated	Canaccord Genuity	Buy
Dec-14-20	Initiated	Cowen	Outperform
Dec-14-20	Initiated	JP Morgan	Overweight
Dec-14-20	Initiated	Jefferies	Buy

View All

Olema Pharmaceuticals Inc Stock (OLMA) Latest News

Sep 12, 2025

Price action breakdown for Olema Pharmaceuticals Inc.2025 Short Interest & Reliable Price Action Trade Plans - Newser

Sep 12, 2025

Should you hold or exit Olema Pharmaceuticals Inc. nowGap Up & Expert Curated Trade Setups - Newser

Sep 12, 2025

Invesco Ltd. Raises Stake in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat

Sep 12, 2025

Does Olema Pharmaceuticals Inc. show high probability of reboundForecast Cut & High Win Rate Trade Alerts - Newser

Sep 12, 2025

OLMA Stock Soars 47% in September So Far on Second PFE Deal - Yahoo Finance

Sep 12, 2025

What data driven models say about Olema Pharmaceuticals Inc.’s futureInsider Buying & Verified Entry Point Detection - Newser

Sep 12, 2025

Olema Pharmaceuticals Inc. recovery potential after sell offAnalyst Downgrade & Weekly High Momentum Picks - Newser

Sep 12, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Upgraded at Zacks Research - Defense World

Sep 12, 2025

Intraday pattern recognizer results for Olema Pharmaceuticals Inc.Gap Down & Free AI Powered Buy and Sell Recommendations - Newser

Sep 12, 2025

Sep 11, 2025

PDT Partners LLC Buys Shares of 74,299 Olema Pharmaceuticals, Inc. $OLMA - MarketBeat

Sep 11, 2025

Pfizer-Olema Collaboration Targets Metastatic Breast Cancer - MSN

Sep 11, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Sep 11, 2025

Heatmap analysis for Olema Pharmaceuticals Inc. and competitorsJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser

Sep 11, 2025

Sep 10, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 7.2%Should You Sell? - MarketBeat

Sep 10, 2025

HC Wainwright Issues Positive Forecast for OLMA Earnings - MarketBeat

Sep 10, 2025

Visualizing Olema Pharmaceuticals Inc. stock with heatmapsTrade Volume Report & Weekly Setup with ROI Potential - Newser

Sep 10, 2025

Published on: 2025-09-10 11:11:24 - Newser

Sep 10, 2025

Is Olema Pharmaceuticals Inc. showing signs of accumulationWeekly Stock Summary & Smart Money Movement Alerts - Newser

Sep 10, 2025

Real time alert setup for Olema Pharmaceuticals Inc. performance2025 Institutional Moves & Fast Exit Strategy with Risk Control - Newser

Sep 10, 2025

What MACD and RSI say about Olema Pharmaceuticals Inc.July 2025 Recap & Free Daily Entry Point Trade Alerts - Newser

Sep 10, 2025

Pfizer (PFE): Evaluating Valuation After New Oncology Partnership With Olema Pharmaceuticals - simplywall.st

Sep 10, 2025

Risk vs reward if holding onto Olema Pharmaceuticals Inc.Weekly Gains Report & Community Trade Idea Sharing - Newser

Sep 10, 2025

Will Olema Pharmaceuticals Inc. see short term momentumEarnings Risk Summary & Advanced Technical Analysis Signals - Newser

Sep 10, 2025

What machine learning models say about Olema Pharmaceuticals Inc.Weekly Profit Summary & Real-Time Buy Signal Notifications - Newser

Sep 10, 2025

What technical models suggest about Olema Pharmaceuticals Inc.’s comebackWeekly Trade Analysis & Low Volatility Stock Recommendations - Newser

Sep 10, 2025

Relative strength of Olema Pharmaceuticals Inc. in sector analysisWeekly Stock Summary & Consistent Income Trade Recommendations - Newser

Sep 10, 2025

Sep 09, 2025

Signal strength of Olema Pharmaceuticals Inc. stock in tech scannersWeekly Trading Summary & Weekly Return Optimization Plans - Newser

Sep 09, 2025

Olema Pharmaceuticals Inc. stock outlook for YEAR2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser

Sep 09, 2025

Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN

Sep 09, 2025

Is Olema Pharmaceuticals Inc. stock poised for growthTrade Performance Summary & Safe Entry Zone Identification - Newser

Sep 09, 2025

Is it too late to sell Olema Pharmaceuticals Inc.July 2025 Price Swings & Advanced Technical Analysis Signals - Newser

Sep 09, 2025

olema pharmaceuticals inc. stock retracement – recovery analysis2025 Market Overview & Free Real-Time Volume Trigger Notifications - Newser

Sep 09, 2025

What moving averages say about Olema Pharmaceuticals Inc.Day Trade & Capital Efficiency Focused Strategies - Newser

Sep 09, 2025